Predict your next investment

RETAIL (NON-INTERNET/MOBILE) | Grocery
shuyupingmin.com

See what CB Insights has to offer

Total Raised

$70.77M

Deal Terms

1

ShuYu Civilian Pharmacy Funding, ShuYu Civilian Pharmacy Valuation & ShuYu Civilian Pharmacy Revenue

2 Fundings

ShuYu Civilian Pharmacy's latest funding round was a IPO for $55.44M on July 6, 2021.

ShuYu Civilian Pharmacy's latest post-money valuation is from July 2021.

Sign up for a free 30-day trial to see ShuYu Civilian Pharmacy's valuations in July 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/6/2021

IPO

$55.44M

$99M

$0.00B

((9.99x))

FY 1234

1

6/25/2018

Corporate Minority

$99M

$0.00B

((9.99x))

FY 1234

10

Date

7/6/2021

6/25/2018

Round

IPO

Corporate Minority

Amount

$55.44M

$99M

Investors

Valuation

$99M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

ShuYu Civilian Pharmacy Deal Terms

1 Deal Term

ShuYu Civilian Pharmacy's deal structure is available for 1 funding round, including their IPO from July 06, 2021.

Round

IPO

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.